Quoin Pharmaceuticals (QNRX)

• Market cap: $13.5M
• 1 day: -1.65%
• 5 days: -1.53%
• 1 month: -11.33%
• 3 months: -61.52%
• 6 months: 13.41%
• Year to date: -40.55%
• 1 year: -32.66%
• 5 years: -99.99%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3